BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 30949194)

  • 1. A novel computational method enables RNA editome profiling during human hematopoiesis from scRNA-seq data.
    Wu Y; Hao S; Xu X; Dong G; Ouyang W; Liu C; Sun HX
    Sci Rep; 2023 Jun; 13(1):10335. PubMed ID: 37365211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Potential Regulation of A-to-I RNA Editing on Genes in Parkinson's Disease.
    Wu S; Xue Q; Qin X; Wu X; Kim P; Chyr J; Zhou X; Huang L
    Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of RNA editing profiles in lung adenocarcinoma.
    Shi S; Chen S; Wang M; Guo B; He Y; Chen H
    Front Genet; 2023; 14():1084869. PubMed ID: 36999050
    [No Abstract]   [Full Text] [Related]  

  • 4. Genome-wide identification of A-to-I RNA editing events provides the functional implications in PDAC.
    Mei Y; Liang D; Ai B; Wang T; Guo S; Jin G; Yu D
    Front Oncol; 2023; 13():1092046. PubMed ID: 36895481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Integrative Studies on the Functional A-to-I RNA Editing Events in Human Cancers.
    Wu S; Fan Z; Kim P; Huang L; Zhou X
    Genomics Proteomics Bioinformatics; 2023 Jun; 21(3):619-631. PubMed ID: 36708807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic control of RNA editing in neurodegenerative disease.
    Wu S; Xue Q; Yang M; Wang Y; Kim P; Zhou X; Huang L
    Brief Bioinform; 2023 Mar; 24(2):. PubMed ID: 36681936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA editing affects cis-regulatory elements and predicts adverse cancer survival.
    Wu YM; Guo Y; Yu H; Guo T
    Cancer Med; 2021 Sep; 10(17):6114-6127. PubMed ID: 34319007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADeditome provides the genomic landscape of A-to-I RNA editing in Alzheimer's disease.
    Wu S; Yang M; Kim P; Zhou X
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33401309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADARs, RNA editing and more in hematological malignancies.
    Teoh PJ; Koh MY; Chng WJ
    Leukemia; 2021 Feb; 35(2):346-359. PubMed ID: 33139858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOBEC3-Mediated RNA Editing in Breast Cancer is Associated with Heightened Immune Activity and Improved Survival.
    Asaoka M; Ishikawa T; Takabe K; Patnaik SK
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advancing Pan-cancer Gene Expression Survial Analysis by Inclusion of Non-coding RNA.
    Ye B; Shi J; Kang H; Oyebamiji O; Hill D; Yu H; Ness S; Ye F; Ping J; He J; Edwards J; Zhao YY; Guo Y
    RNA Biol; 2020 Nov; 17(11):1666-1673. PubMed ID: 31607216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic Positional Dissection of RNA Editomes in Tumor and Normal Samples.
    Chigaev M; Yu H; Samuels DC; Sheng Q; Oyebamiji O; Ness S; Yue W; Zhao YY; Guo Y
    Front Genet; 2019; 10():211. PubMed ID: 30949194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum: Genomic Positional Dissection of RNA Editomes in Tumor and Normal Samples.
    Chigaev M; Yu H; Samuels DC; Sheng Q; Oyebamiji O; Ness S; Yue W; Zhao YY; Guo Y
    Front Genet; 2020; 11():162. PubMed ID: 32161619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-Wide Characterization of RNA Editing Sites in Primary Gastric Adenocarcinoma through RNA-seq Data Analysis.
    Behroozi J; Shahbazi S; Bakhtiarizadeh MR; Mahmoodzadeh H
    Int J Genomics; 2020; 2020():6493963. PubMed ID: 33415135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A computational screen for site selective A-to-I editing detects novel sites in neuron specific Hu proteins.
    Ensterö M; Akerborg O; Lundin D; Wang B; Furey TS; Ohman M; Lagergren J
    BMC Bioinformatics; 2010 Jan; 11():6. PubMed ID: 20047656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A-to-I RNA editing as a tuner of noncoding RNAs in cancer.
    Liao Y; Jung SH; Kim T
    Cancer Lett; 2020 Dec; 494():88-93. PubMed ID: 32822814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolutionary driving forces of A-to-I editing in metazoans.
    Duan Y; Tang X; Lu J
    Wiley Interdiscip Rev RNA; 2022 Jan; 13(1):e1666. PubMed ID: 33998151
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.